Medicine and Dentistry
Electrical Brain Stimulation
100%
Parkinson's Disease
44%
Essential Tremor
38%
Globus pallidus
26%
Intraoperative MRI
25%
Symptom
23%
Rating Scale
20%
Treatment of Parkinson's Disease
19%
Dystonia
19%
Microelectrode
18%
Subthalamic Nucleus
16%
Surgery
16%
Infection
15%
Dyskinesia
14%
Tardive Dyskinesia
12%
Dural Arteriovenous Fistula
12%
Paraplegia
12%
Pathognomonic
12%
Telemedicine
12%
Hemiballism
12%
Edema
12%
Quality of Life
10%
Epileptic Seizure
9%
Adverse Event
9%
Pelvis
8%
Bleeding
8%
Drug Therapy
7%
Surgical Technique
7%
Stereotypic Movement Disorder
7%
Unified Parkinson's Disease Rating Scale
7%
Brain Cyst
6%
Internal Capsule
6%
Spasmodic torticollis
5%
Cognition
5%
Keyphrases
Deep Brain Stimulation
40%
Essential Tremor
25%
Clinical Outcomes
19%
Parkinson Patients
19%
Lead Placement
17%
Stimulation Current
12%
Subthalamic nucleus Deep Brain Stimulation (STN-DBS)
12%
Copulatory
12%
Parafascicular nucleus
12%
Edema
12%
Telemedicine
12%
Subthalamic
12%
Prospective Longitudinal Study
12%
Mild Cognitive Impairment
12%
Parkinson's Disease
12%
Conversion Rate
12%
Wearable Motion Sensors
12%
Cognitive Dementia
12%
Dystonia
12%
Operative
12%
Intraoperative Magnetic Resonance Imaging (iMRI)
12%
Long-term Clinical Outcome
12%
Pallidal Deep Brain Stimulation
12%
DBS Surgery
10%
Quality of Life
10%
Adverse Events
8%
Cognitive Function
8%
Unified Parkinson's Disease Rating Scale (UPDRS)
6%
Older Patients
6%
Dementia
6%
MRI-guided
6%
Serious Complications
6%
Microelectrode Recording
6%
Deep Brain Stimulation Surgery
6%
Serious Adverse Events
5%
Motor Outcome
5%
Seizure
5%
PDQ-39
5%
Parkinson's Disease Questionnaire
5%
Motor Score
5%
Gait Difficulty
5%
Neuroscience
Parkinson's Disease
65%
Electrical Brain Stimulation
50%
Essential Tremor
38%
Subthalamic Nucleus
25%
Tremor
15%
Longitudinal Study
12%
Centromedian Nucleus
12%
Mild Cognitive Impairment
12%
Globus pallidus
12%
Treatment of Parkinson's Disease
12%
Stereotypic Movement Disorder
9%
Thalamus
5%
Functional Magnetic Resonance Imaging
5%
Multiple System Atrophy
5%
Progressive Supranuclear Palsy
5%